FSA Group Extends Securitisation Run With $200 Million ABS Deal
FSA Group has priced a $200 million asset-backed securities transaction, giving the specialist lender another funding milestone as it expands its securitisation program. Settlement is expected in November, although customary conditions precedent still need to be satisfied.
- $200 million Azora ABS 2026-1P transaction priced
- Backed by automobile and equipment consumer and commercial receivables
- Third ABS transaction for FSA Group
- Settlement expected in November, subject to customary conditions
- Pricing, funding costs and tranche details not disclosed
Add us as a preferred source on Google
Third Securitisation Adds $200 Million Funding Capacity
FSA Group Limited (ASX:FSA) has priced a $200 million asset-backed securities transaction backed by automobile and equipment consumer and commercial receivables. Named Azora ABS 2026-1P, the deal marks the company’s third ABS transaction.
The announcement does not disclose the transaction’s pricing, funding cost, tranche structure or credit enhancement. That leaves the headline amount as the clearest measure of scale, rather than a complete picture of the economics for FSA Group or its investors.
Azora ABS 2026-1P Extends Securitisation Program
The new deal extends a financing strategy that has already included the second ABS issuance, which was a $300 million transaction backed by automobile and equipment receivables. The latest announcement does not state how the new issuance will affect receivables growth, leverage or earnings.
Westpac Banking Corporation acted as arranger, while National Australia Bank and Westpac served as joint lead managers. Settlement is expected in November 2026, subject to customary conditions precedent, so the transaction has been priced but is not yet complete.
November Settlement Is the Next Test
For shareholders, the immediate point to track is whether settlement proceeds as expected and what funding terms accompany it. Until those details emerge, the announcement confirms another source of financing for FSA Group’s receivables platform but offers limited visibility on the transaction’s direct financial contribution.
Bottom Line?
The third ABS deal strengthens the funding narrative, but its ultimate value will depend on settlement and the undisclosed cost of capital.
Questions in the middle?
- Will Azora ABS 2026-1P settle on schedule in November 2026?
- What pricing and funding costs will FSA Group incur on the new transaction?
- How will the $200 million issuance affect receivables growth, leverage and earnings?
Sources
1-
FSA Group prices $200m ABS transaction (opens in a new tab)Official market announcement. Fsa Group Limited · 29 Oct 2026 · fsagroup.com.au